S713 Induction and Maintenance Treatment with Risankizumab Leads to Symptomatic Relief in Patients With Moderate to Severe Crohn's Disease. (October 2022) - Louis, Edouard; Torres, Joana; Lindsay, James; Schreiber, Stefan; Jonaitis, Laimas; Kligys, Kristina; Van Haaren, Stijn; Neimark, Ezequiel; Zambrano, Javier; Zhang, Yafei; D'Haens, Geert